TrialObesity (Silver Spring, Md.)2023

Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial.

Carlos M Grilo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.